An open trial regarding the safety and efficacy of blonanserin for patients with gambling disorder
Not Applicable
- Conditions
- Gambling disorder
- Registration Number
- JPRN-UMIN000020669
- Lead Sponsor
- Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
Not provided
Exclusion Criteria
1. Incompetent 2. Pregnant, nursing, or being expected as so 3. F2 or F0 by ICD-10 4. uncontrolled physical illness 5. taking antipsychotic drugs within 28 days before 6. taking prohibited with blonanserin 7. history of allergic reaction for blonanserin 8. history of malignant syndrome or tardive dyskinesia caused by antipsychotic drugs 9. participated other clinical trials within 3 month before 10. 15 >= MADRS 11. 15 >= YMRS 12. 3 >= overall severity of DIEPSS 13. history of suicide attempt within one years before 14. contraindicated by the doctor in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall severity of DIEPSS at 8 weeks
- Secondary Outcome Measures
Name Time Method The change of the scores in GSAS, PG-YBOCS, BIS-11, and CGI-C at 8 weeks